Cargando…
Gadobutrol in Renally Impaired Patients: Results of the GRIP Study
OBJECTIVE: The aim of this study was to assess the potential risk of gadobutrol-enhanced magnetic resonance imaging (MRI) in patients with moderate to severe renal impairment for the development of nephrogenic systemic fibrosis (NSF). MATERIALS AND METHODS: We performed a prospective, international,...
Autores principales: | Michaely, Henrik J., Aschauer, Manuela, Deutschmann, Hannes, Bongartz, Georg, Gutberlet, Matthias, Woitek, Ramona, Ertl-Wagner, Birgit, Kucharczyk, Walter, Hammerstingl, Renate, De Cobelli, Francesco, Rosenberg, Martin, Balzer, Thomas, Endrikat, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145251/ https://www.ncbi.nlm.nih.gov/pubmed/27529464 http://dx.doi.org/10.1097/RLI.0000000000000307 |
Ejemplares similares
-
Gadobutrol in India—A Comprehensive Review of Safety and Efficacy
por: Endrikat, Jan, et al.
Publicado: (2017) -
Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million Applications
por: Endrikat, Jan, et al.
Publicado: (2016) -
Safety of gadobutrol: results of a non-interventional study of 3710
patients, including 404 children
por: Glutig, Katja, et al.
Publicado: (2018) -
Steady state vascular imaging with extracellular gadobutrol: evaluation of the additional diagnostic benefit in patients who have undergone a peripheral magnetic resonance angiography protocol
por: Ong, Melissa M, et al.
Publicado: (2013) -
Gadobutrol: Fatal anaphylaxis: case report
Publicado: (2021)